# A Study to Determine the Safety and Efficacy of TG-C in Subjects With Kellgren and Lawrence Grade 2 or 3 OA of the Knee

> **NCT03203330** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Kolon TissueGene, Inc.** · enrollment: 535 (actual)

## Conditions studied

- Degenerative Osteoarthritis

## Interventions

- **BIOLOGICAL:** TG-C
- **BIOLOGICAL:** Placebo Control

## Key facts

- **NCT ID:** NCT03203330
- **Lead sponsor:** Kolon TissueGene, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-10-30
- **Primary completion:** 2024-07-10
- **Final completion:** 2026-07-10
- **Target enrollment:** 535 (ACTUAL)
- **Last updated:** 2025-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03203330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03203330, "A Study to Determine the Safety and Efficacy of TG-C in Subjects With Kellgren and Lawrence Grade 2 or 3 OA of the Knee". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03203330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*